JERUSALEM (Reuters) - Teva Pharmaceutical Industries will cut about 5,000 jobs, 10 percent of its workforce, accelerating a cost-cutting plan as it prepares for lower-priced competition for its best-selling drug.
Teva , the world's largest maker of generic drugs, said it expects to save about $2 billion a year by the end of 2017.
The Israel-based company is the latest in a string of big drugmakers to take an axe to costs. Last week, Merck & Co said it would cut annual operating costs by $2.5 billion and eliminate 8,500 jobs, or more than 10 percent of its global workforce.
http://www.dailypress.com/business/sns-rt-us-teva-20131010,0,7930827.story?
Teva , the world's largest maker of generic drugs, said it expects to save about $2 billion a year by the end of 2017.
The Israel-based company is the latest in a string of big drugmakers to take an axe to costs. Last week, Merck & Co said it would cut annual operating costs by $2.5 billion and eliminate 8,500 jobs, or more than 10 percent of its global workforce.
http://www.dailypress.com/business/sns-rt-us-teva-20131010,0,7930827.story?
No comments:
Post a Comment